StocksFin Logo
Evotec SE country of incorporation
|
|
4,715 employees
NASDAQ | Healthcare | Drug Manufacturers—Specialty & Generic
HealthEquity, Inc. country of incorporation
|
|
Mr. Jon Kessler
|
3,688 employees
NASDAQ | Healthcare | Health Information Services
Q322 reported Sep 30, 2022 Reporting Period
$173.88M 8.9% vs. Q321 Revenues Q322
16.34% -39.5% vs. Q321 Gross Profit Margin
-27.19% ! -132.3% vs. Q321 Net Profit Margin
-79.81M ! -483.8% vs. Q321 Free Cash Flow Q322
$-0.14 ! -132.9% vs. Q321 EPS Q322
Period
Profitable?
Revenue Growth?
Net Profit Growth?
FCF Growth?
OCF Growth?
EPS Growth?
Pays Dividend?
Q322
Q323
Q323 reported Dec 8, 2022 Reporting Period
$216.09M 20.1% vs. Q322 Revenues Q323
58.71% 2.3% vs. Q322 Gross Profit Margin
-0.76% ! 72.9% vs. Q322 Net Profit Margin
37.85M 70% vs. Q322 Free Cash Flow Q323
$-0.02 ! 68.3% vs. Q322 EPS Q323
-
Period
Profitable?
Revenue Growth?
Net Profit Growth?
FCF Growth?
OCF Growth?
EPS Growth?
Pays Dividend?
Q322
Q323
Loading...
Loading...
Ratios
As of
Dec 31, 2022
Oct 31, 2022
Quick Ratio
2.92
2.7
Current Ratio
3.18
3.01
Cash Ratio
1.23
1.9
Price to Book
2.25
3.5
Price to Sales
3.55
30.49
Price to Earnings
-15.19
-1000